Superstring-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
34
Total Value
84048298
Accession Number
0001931118-25-000004
Form Type
13F-HR
Manager Name
Superstring-Capital-Management-Lp
Data Enrichment
97% identified
33 identified1 unidentified

Holdings

34 positions • $84.0M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
MoonLake Immunotherapeutics
Shares:32.1K
Value:$1.3M
% of Portfolio:1.5% ($1.3M/$84.0M)
Taysha Gene Therapies, Inc.
Shares:755.6K
Value:$1.1M
% of Portfolio:1.2% ($1.1M/$84.0M)
Tectonic Therapeutic, Inc.
Shares:50.7K
Value:$898.7K
% of Portfolio:1.1% ($898.7K/$84.0M)
Zenas BioPharma, Inc.
Shares:111.6K
Value:$881.7K
% of Portfolio:1.0% ($881.7K/$84.0M)
89bio, Inc.
Shares:109.2K
Value:$793.6K
% of Portfolio:0.9% ($793.6K/$84.0M)
Avidity Biosciences, Inc.
Shares:22.3K
Value:$657.4K
% of Portfolio:0.8% ($657.4K/$84.0M)
Cabaletta Bio, Inc.
Shares:459.0K
Value:$635.7K
% of Portfolio:0.8% ($635.7K/$84.0M)
Vaxcyte, Inc.
Shares:11.3K
Value:$425.3K
% of Portfolio:0.5% ($425.3K/$84.0M)
Kyverna Therapeutics, Inc.
Shares:191.3K
Value:$369.2K
% of Portfolio:0.4% ($369.2K/$84.0M)
OCULAR THERAPEUTIX, INC
Shares:42.3K
Value:$310.0K
% of Portfolio:0.4% ($310.0K/$84.0M)
Schrodinger, Inc.
Shares:14.1K
Value:$278.6K
% of Portfolio:0.3% ($278.6K/$84.0M)
Century Therapeutics, Inc.
Shares:463.0K
Value:$220.4K
% of Portfolio:0.3% ($220.4K/$84.0M)
CUMBERLAND PHARMACEUTICALS INC
Shares:50.0K
Value:$211.5K
% of Portfolio:0.3% ($211.5K/$84.0M)
G9845F208
Shares:30.8K
Value:$74.5K
% of Portfolio:0.1% ($74.5K/$84.0M)